Global Clinical Trial Management Market | Growth, Analysis

1
The Global Clinical Trial Management Market to
Develop at CAGR of 10.92 by 2028
Triton Market Research presents the Global
Clinical Trial Management Market segmented by
Product Type (Site-based CTM, Enterprise-based
CTM), Deployment Mode (On-Premise Deployment,
Web-based Deployment, Cloud-based Deployment),
End-user (Clinical Research Organizations,
Pharmaceutical Biopharmaceutical Companies,
Healthcare Providers), Component (Hardware,
Services, Software), and Geography (North
America, Asia-Pacific, Latin America, Middle East
and Africa, Europe). The report further discusses
the Market Summary, Industry Outlook, Market
Scope, Key Insights, Porter's Five Forces
Analysis, Market Attractiveness Index, Vendor
Scorecard, Drivers, Restraints, Opportunities,
Key Strategic Developments, Impact of COVID-19,
Competitive Landscape, Research Methodology
Scope, Global Market Size, Forecasts Analysis
(2021-2028).
GLOBAL CLINICAL TRIAL MANAGEMENT MARKET
2021-2028 CAGR 10.92 The regional paradigm of
CLINICAL TRIAL MANAGEMENT Market was dominated by
North America by capturing a majority of revenue
share. On other hand, Asia-Pacific is anticipated
to be the fastest growing regional market over
the forecast period. www.tritonmarketresearch.com
Request a Free Sample https//www.tritonmarketres
earch.com/reports/clinical-trial-management-market
request-free-sample Triton's report implies that
the global market for clinical trial management
is expected to propel at a CAGR of 10.92 over
the estimated years 2021-2028.
Clinical trial management contains hardware,
software, and services engaged in maintaining and
managing high data volume derived from clinical
trials conducted across various organizations.
These systems offer several benefits to pharma
companies to supervise and obtain data whenever
needed.
2
Factors such as growth in clinical trials, along
with outsourcing clinical trials for cost
reduction, are opening multiple avenues for the
development of the clinical trial management
market worldwide. The technological advancements
and rise in demand for better drugs with lesser
side effects have led to an increase in the
number of clinical trials globally. Here, the
innovation in data management, AI, and
biotechnology is also accelerating the discovery
of novel treatments, increasing the need for more
clinical trials. However, the lack of a skilled
workforce, high cost of implementation, and
concerns regarding the security of CTM systems
are obstructing the global market's future
growth. North America holds the largest market
for clinical trial management and is likely to
continue its hold over the market till 2028. Over
the years, there has been a considerable growth
in the demand for clinical trial management,
owing to the well-developed healthcare
infrastructure across the region's nations.
Moreover, an increase in the number of clinical
trials further stimulates the studied market's
progress across the region. In the US and Canada,
the presence of several major pharma companies
and growing awareness about the benefits of using
CTM systems are another set of factors
responsible for expanding the clinical trial
management market within North America. The
distinguished companies thriving in the clinical
trial management market comprise IBM Corporation,
Advarra (Forte Research Systems Inc), Oracle
Corporation, Medidata Solutions Inc, Parexel
International Corporation, Veeva Systems Inc,
Mednet Solutions Inc, Bio-Optronics Inc,
Arisglobal LLC, and Bioclinica Inc. The
investment cost for the new market players is
moderately high. Moreover, there is continual
support from the government and other
organizations to enhance the RD sector. This
suggests that the threat of new entrants is
likely to be moderate. On the other hand, the
demand for CTM is rising due to the increase in
awareness about the benefits offered by these
systems. Hence, the competition among the
existing players is expected to remain relatively
high.
Contact Us sales_at_tritonmarketresearch.com Phone
44 7441 911839